» Articles » PMID: 34006298

The Effect of SOX4 Gene 3'UTR Polymorphisms on Osteoporosis

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2021 May 19
PMID 34006298
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to explore the correlation between the SRY-related high-mobility-group box gene 4 (SOX4) 3' untranslated region (UTR) single nucleotide polymorphism (SNP) and osteoporosis susceptibility.

Methods: The study recruited 330 osteoporosis patients (the case group) and 330 non-osteoporosis patients (the control group) in Sichuan Chengdu First People's Hospital and Zibo Central Hospital from August 2016 to August 2019. Sanger sequencing was used to analyze the genotypes of SOX4 gene rs79958549, rs139085828, and rs201335371 loci. Multi-factor dimensionality reduction (MDR) was used to analyze the interaction between the SOX4 gene rs79958549, rs139085828, and rs201335371 loci and the clinical characteristics of the subjects.

Results: The risk of osteoporosis in the carriers of A allele at SOX4 rs79958549 was 5.40 times that in the carriers of the G allele (95% CI 3.25-8.96, P < 0.01). The risk of osteoporosis in the carriers of the A allele at SOX4 rs139085828 was 1.68 times that in the carriers of the G allele (95% CI 1.45-1.85, P < 0.01). The risk of osteoporosis in the carriers of the T allele at SOX4 rs201335371 was 0.54 times that in the carriers of the C allele (95% CI 0.43-0.69, P < 0.01). The SOX4 gene rs79958549, rs139085828, and rs201335371 A-A-C haplotype (OR = 5.14, 95% CI 2.45-10.57, P < 0.01) were associated with increased risk of osteoporosis and G-G-T haplotype was significantly associated with decreased risk of osteoporosis (OR = 0.48, 95% CI 0.38-0.62, P < 0.01). The interaction among the factors of sex, smoking, drinking, rs79958549, rs201335371 was the best model for osteoporosis prediction, and the risk for osteoporosis in 'high-risk combination' was 2.74 times that of 'low-risk combination' (95% CI 1.01-7.43, P = 0.04). Multiple logistic regression analysis revealed that the risk factors for osteoporosis were BMD (OR = 5.85, 95% CI 2.88-8.94, P < 0.01), T score (OR = 8.54, 95% CI 5.66-10.49, P < 0.01), Z score (OR = 3.77, 95% CI 2.15-8.50, P < 0.01), rs79958549 SNP (OR = 6.92, 95% CI 3.58-8.93, P < 0.01), and rs139085828 SNP (OR = 2.36, 95% CI 1.85-4.27, P < 0.01). The protective factor for osteoporosis was rs201335371SNP (OR = 0.48, 95% CI 0.32-0.75, P < 0.01).

Conclusion: The SOX4 gene SNPs rs79958549, rs139085828, and rs201335371 loci were significantly associated with osteoporosis risk.

Citing Articles

Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women.

Bao X, Liu C, Liu H, Wang Y, Xue P, Li Y J Orthop Surg Res. 2024; 19(1):869.

PMID: 39716293 PMC: 11667832. DOI: 10.1186/s13018-024-05361-z.


SOXC are critical regulators of adult bone mass.

Angelozzi M, Karvande A, Lefebvre V Nat Commun. 2024; 15(1):2956.

PMID: 38580651 PMC: 10997656. DOI: 10.1038/s41467-024-47413-2.


Regulatory mechanisms of circular RNAs during human mesenchymal stem cell osteogenic differentiation.

Mazziotta C, Badiale G, Cervellera C, Tognon M, Martini F, Rotondo J Theranostics. 2024; 14(1):143-158.

PMID: 38164139 PMC: 10750202. DOI: 10.7150/thno.89066.


SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis.

Ahmed E, Alzahrani A Int J Mol Sci. 2023; 24(4).

PMID: 36835620 PMC: 9967432. DOI: 10.3390/ijms24044215.


The Role of SOX Transcription Factors in Ageing and Age-Related Diseases.

Stevanovic M, Lazic A, Schwirtlich M, Stanisavljevic Ninkovic D Int J Mol Sci. 2023; 24(1).

PMID: 36614288 PMC: 9821406. DOI: 10.3390/ijms24010851.


References
1.
Duncan E, Danoy P, Kemp J, Leo P, McCloskey E, Nicholson G . Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet. 2011; 7(4):e1001372. PMC: 3080863. DOI: 10.1371/journal.pgen.1001372. View

2.
Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

3.
Sinclair A, Berta P, Palmer M, Hawkins J, GRIFFITHS B, Smith M . A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990; 346(6281):240-4. DOI: 10.1038/346240a0. View

4.
Nissen-Meyer L, Jemtland R, Gautvik V, Pedersen M, Paro R, Fortunati D . Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J Cell Sci. 2007; 120(Pt 16):2785-95. DOI: 10.1242/jcs.003855. View

5.
Aspray T, Hill T . Osteoporosis and the Ageing Skeleton. Subcell Biochem. 2019; 91:453-476. DOI: 10.1007/978-981-13-3681-2_16. View